Immunotherapy in gynecological cancers

Immunotherapy has changed the natural history of several malignancies that, a decade ago, had a very poor prognosis, such as lung cancer and melanoma. Consequently, many attempts have been done to expand the indications of immunotherapy agents, predominantly immune checkpoint inhibitors (ICIs), in o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorusso, Domenica, Ceni, Valentina, Daniele, Gennaro, Pietragalla, Antonella, Salutari, Vanda, Muratore, Margherita, Nero, Camilla, Ciccarone, Francesca, Scambia, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400773/
https://www.ncbi.nlm.nih.gov/pubmed/36046088
http://dx.doi.org/10.37349/etat.2021.00033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400773/
https://www.ncbi.nlm.nih.gov/pubmed/36046088
http://dx.doi.org/10.37349/etat.2021.00033

Ejemplares similares